In the run up to GCV Symposium, we were delighted to offer the first in-person conduct of the Institute’s noted CVC Investment Programs course, kindly hosted by Brown Rudnick in London. Participants appreciated the additional time for personal interaction and networking. They highlighted expert panel Q&A discussions that applied course concepts to speakers’ individual programs and challenges as being among the most valuable elements in the course. The peer breakouts were lively, and the discussions continued in the pub afterwards – a rare opportunity in recent times!
Expert panelists included David Gilmour (ex-BP Ventures Head), Eileen Tanghal (In-Q-Tel), Markus Moore (Emerald Technology Ventures) and Neil Foster (Brown Rudnick). We also welcomed two CVC-backed startup founders, Chris Sheldrick of What3Words and Gilad Gershon of Tropic Biosciences, who didn’t hold back on what they expected to see from strategic investors. Further insights were provided through our expert video case studies delivered by Bill Taranto (Merck Global Health Innovation), George Hoyem (In-Q-Tel), Rob Coppedge (Echo Health Ventures), David Hayes (BP Ventures), Jody Thelander (J Thelander Compensation), Debra Brackeen (CSAA Insurance Group) and DLA Piper.
Participants included representatives from the National Security Strategic Investment Fund (NSSIF), LG, Neom, PWC, Borg Warner, Saint-Gobain and Doral Energy Tech Ventures. We’re really looking forward to delivering more in-person programmes aligned with GCV events as we move into 2022, with the February GCVI Summit next on the agenda. Further info found here.
1 December 2021, GCV Institute Bulletin Extract